J Retin.  2024 Nov;9(2):204-209. 10.21561/jor.2024.9.2.204.

Four Cases of 0.625% Povidone-Iodine Intravitreal Injection Followed by Vitrectomy for Acute Endophthalmitis after Cataract Surgery: Case Report

Affiliations
  • 1Department of Ophthalmology, Nune Eye Hospital, Namyangju, Korea
  • 2Department of Ophthalmology, Nune Eye Hospital, Daegu, Korea
  • 3Department of Ophthalmology, School of Medicine, Kyungpook National Universtiy, Daegu, Korea

Abstract

Purpose
We sought to report the results of 0.625%/0.1 mL of povidone–iodine (PI) intravitreal injection (0.013% PI vitreous concentration) for treating acute endophthalmitis after cataract surgery.
Case summary
Case 1 developed acute endophthalmitis one day after cataract surgery. Prompt intervention with PI injection and vitrectomy led to full resolution of inflammation and a visual acuity of 0.8, and the patient remained stable at 10 months. Case 2, a patient with persistent post-cataract inflammation, was treated with PI injection and vitrectomy, resulting in complete resolution of inflammation and improvement of visual acuity to 0.6 by eight months. Case 3 was a diabetic patient who experienced severe acute endophthalmitis. The patient was treated with the above intervention, resulting in full resolution of endophthalmitis; however, he eventually lost vision due to neovascular glaucoma. Case 4 developed recurrent endophthalmitis caused by Achromobacter xylosoxidans after cataract surgery. This patient required multiple vitrectomies, PI injections, and intraocular lens removal, which led to a resolution of inflammation and restoration of visual acuity to 1.0 after 14 months.
Conclusions
0.625%/0.1-mL IPI injection followed by vitrectomy was performed in four acute endophthalmitis patients after cataract surgery and were successfully treated.

Keyword

Cataract extraction; Endophthalmitis; Intravitreal injection; Povidone-Iodine
Full Text Links
  • JR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr